Isolation and characterization of a proteoglycan variant from human aorta exhibiting a marked affinity for low density lipoprotein and demonstration of its enhanced expression in atherosclerotic plaques

Atherosclerosis

Volumn 127, Issue 2, 1996, Pages 195-203

  Vijayagopal, Parakat ^a   Figueroa, Julio E ^a   Fontenot, Jason D ^a   Glancy, D Luke ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

atherogenesis; foam cell formation; LDL binding; proteoglycans

Indexed keywords

LOW DENSITY LIPOPROTEIN; PROTEOGLYCAN;

AORTA; ARTICLE; ATHEROSCLEROSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; ION EXCHANGE CHROMATOGRAPHY; LIPID BLOOD LEVEL; LIPID METABOLISM; MACROPHAGE; MONOCYTE; PLAQUE FORMING CELL; PRIORITY JOURNAL;

AGED; AORTA; ARTERIOSCLEROSIS; BINDING SITES; CARRIER PROTEINS; CELLS, CULTURED; CHOLESTEROL ESTER TRANSFER PROTEINS; CHROMATOGRAPHY, AFFINITY; CHROMATOGRAPHY, ION EXCHANGE; GLYCOPROTEINS; HUMANS; LIPOPROTEINS, LDL; MACROPHAGES; MIDDLE AGED; PROTEOGLYCANS;

EID: 0030595998     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(96)05954-0     Document Type: Article

References (36)

1. [1] Wight TN. Cell biology of arterial proteoglycans. Arteriosclerosis 1989;9:1.
2. [2] Camejo G. The interaction of lipids and lipoproteins with the extracellular matrix of arterial tissue. Adv Lipid Res 1982;19:1.
3. [3] Berenson GS, Radhakrishnamurthy B, Srinivasan SR, Vijayagopal P, Dalferes ER Jr, Sharma C. Recent advances in molecular pathology. Carbohydrate-protein macromolecules and arterial wall integrity - a role in atherogenesis. Exp Mol Pathol. 1984;41:267.
4. [4] Srinivasan SR, Dolan P, Radhakrishnamurthy B, Pargaonkar PS, Berenson GS. Lipoprotein-acid mucopolysaccharide complexes of human atherosclerotic lesions. Biochim Biophys Acta 1975;388:58.
5. [5] Mawhinney TP, Augustyn JM, Fritz KE. Glycosaminoglycan-lipoprotein complexes from aortas of hypercholesterolemic rabbits: Part I. Isolation and characterization. Atherosclerosis 1978;31:155.
6. [6] Vijayagopal P, Srinivasan SR, Jones KM, Radhakrishnamurthy B, Berenson GS. Complexes of low-density lipoproteins and arterial proteoglycan aggregates promote cholesteryl ester accumulation in mouse macrophages. Biochim Biophys Acta 1985;837:251.
7. [7] Salisbury BG, Falcone DJ, Minick CR. Insoluble low-density lipoprotein-proteoglycan complexes enhance cholesteryl ester accumulation in macrophages. Am J Pathol 1985;120:6.
8. [8] Hurt E, Bondjers G, Camejo G. Interaction of LDL with human arterial proteoglycans stimulates its uptake by human monocyte-derived macrophages. J Lipid Res 1990;31:443.
9. [9] Vijayagopal P, Srinivasan SR, Radhakrishnamurthy B, Berenson GS. Lipoprotein-proteoglycan complexes from atherosclerotic lesions promote cholesteryl ester accumulation in human monocytes/macrophages. Arterioscler Thromb 1992;12:237.
10. [10] Vijayagopal P, Srinivasan SR, Radhakrishnamurthy B, Berenson GS. Interaction of serum lipoproteins and a proteoglycan from bovine aorta. J Biol Chem 1981;256:8234.
11. [11] Vijayagopal P, Srinivasan SR, Radhakrishnamurthy B, Berenson GS. Hemostatic properties and serum lipoprotein binding of a heparan sulfate proteoglycan from bovine aorta. Biochim Biophys Acta 1983;758:70.
12. [12] Srinivasan SR, Vijayagopal P, Eberle K, Dalferes ER Jr, Radhakrishnamurthy B, Berenson GS. Low density lipoprotein binding affinity of arterial wall isomeric chondroitin sulfate proteoglycans. Atherosclerosis 1988;72:1.
13. [13] Srinivasan SR, Vijayagopal P, Eberle K, Radhakrishnamurthy B, Berenson GS. Low-density lipoprotein binding affinity of arterial wall proteoglycans: characteristics of a chondroitin sulfate proteoglycan subfraction. Biochim Biophys Acta 1989;1006:159.
14. [14] Ross R. The pathogenesis of atherosclerosis - an update. N Engl J Med. 1986;314:488.
15. [15] Srinivasan SR, Xu JH, Vijayagopal P, Radhakrishnamurthy B, Berenson GS. Injury to the arterial wall of rabbits produces proteoglycan variants with enhanced low-density lipoprotein-binding property. Biochim Biophys Acta 1993;1168:158.
16. [16] Cardoso LE, Mourao PA. Glycosaminoglycan fractions from human arteries presenting diverse susceptibilities to atherosclerosis have different binding affinities to plasma LDL. Arterioscler Thromb 1994;14:115.
17. [17] Coinu R, Cherchi G, Formato M, Demuro P, De Luca G. LDL interaction with proteoglycans isolated from human aortas with different atherosclerotic involvement. Haematologica 1993;78:270.
18. [18] Carrino DA, Arias JL, Caplan AI. A spectrophotometric modification of a sensitive densitometric Safranin-O assay for glycosaminoglycans. Biochem Int 1991;24:485.
19. [19] Blumenkratz N, Asboe-Hansen G. New method for quantitative determination of uronic acids. Anal Biochem 1973;54:484.
20. [20] Hatch FT, Lees RS. Practical method for plasma lipoprotein analysis. Adv Lipid Res 1968;6:2.
21. [21] Christner JE, Caterson B, Baker JR. Immunological determinants of proteoglycans. Antibodies against the unsaturated oligosaccharide products of chondroitinase ABC-digested cartilage proteoglycans. J Biol Chem 1980;255:7102.
22. [22] Vijayagopal P. Enhanced synthesis and accumulation of proteoglycans in cholesterol-enriched arterial smooth muscle cells. Biochem J 1993;294:603.
23. [23] Vijayagopal P, Srinivasan SR, Radhakrishnamurthy B, Berenson GS. Human monocyte-derived macrophages bind low-density-lipoprotein-proteoglycan complexes by a receptor different from the low-density-lipoprotein receptor. Biochem J 1993;289:837.
24. [24] Boyum A. Isolation of lymphocytes, granulocytes, and macrophages. Scand J Immunol 1976;5(Suppl 5):9.
25. [25] Dalferes E Jr, Radhakrishnamurthy B, Ruiz HA, Berenson GS. Composition of proteoglycans from human atherosclerotic lesions. Exp Mol Pathol 1987;47:363.
26. [26] Kumar V, Berenson G, Ruiz H, Dalferes E Jr, Strong J. Acid mucopolysaccharides of human aorta. Pari 2. Variations with atherosclerotic involvement. J Atheroscler Res 1967;7:583.
27. [27] Smith E. The influence of age on the chemistry of aortic intima, collagen and mucopolysaccharides. J Atheroscler Res 1965;5:241.
28. [28] Stevens R, Colombo M, Gonzales J, Hollander W, Schmid K. The glycosaminoglycans of the human artery and their changes in atherosclerosis. J Clin Invest 1976;58:470.
29. [29] Camejo G, Fager G, Rosengren B, Hurt-Camejo E, Bondjers G. Binding of low density lipoproteins by proteoglycans synthesized by proliferating and quiescent human arterial smooth muscle cells. J Biol Chem 1993;268:14 131.
30. [30] Hurt-Camejo E, Camejo G, Rosengren B et al. Effect of arterial proteoglycans and glycosaminoglycans on low density lipoprotein oxidation and its uptake by human macrophages and arterial smooth muscle cells. Arterioscler Thromb 1992;12: 569.
31. [31] Steinberg D, Parthasarathy S, Carew T, Khoo J, Witzum J. Beyond cholesterol. Modifications of low density lipoprotein that increase its atherogenicity. New Engl J Med 1989;320:915.
32. [32] Wegrowski J, Moczar M, Robert L. Proteoglycans from pig aorta. Comparative study of their interactions with lipoproteins. Biochem J 1986;235:823.
33. [33] Iverius PH. The interaction between human plasma lipoproteins and connective tissue glycosaminoglycans. J Biol Chem 1973;247:2607.
34. [34] Mourao PAS, Pillai S, Di Ferranti N. The binding of chondroitin 6-sulfate to plasma low density lipoprotein. Biochim Biophys Acta 1981;674:178.
35. [35] Srinivasan SR, Lopez SA, Radhkrishnamurthy B, Berenson GS. Complexes of serum pre-B-and B-lipoproteins and acid mucopolysaccharides. Atherosclerosis 1970;12:321.
36. [36] Mourao PAS, Bracamonte CA. The binding of human aortic glycosaminoglycans and proteoglycans to plasma low density lipoproteins. Atherosclerosis 1984;50:133.